Yet, a previous study among participants of FHS demonstrated increased brain amyloid‐β deposition and tau pathology, which are direct AD markers, in relation to NAFLD [32]. This evidence concerns the gene MAPT and metabolic dysfunction-associated steatotic liver disease.